Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

UMHS opens Massey Emergency Critical Care Center

They come from highway accident scenes and nursing home beds, from factories and farm fields, from suburban homes, downtown sidewalks and small community hospitals.

16 Feb 2015

Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Pediatric cardiology researchers and clinicians from numerous centers from around the world are gathering at the Cardiology 2015: the 18th Annual Update on Pediatric and Congenital Cardiovascular Disease conference, sponsored by The Children's Hospital of Philadelphia and Phoenix Children's Hospital on Feb. 11 to Feb. 15 in Scottsdale, Ariz.

16 Feb 2015

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Sudden cardiac arrest is a possible cause of death in patients with non-ischaemic cardiac muscle weakness, i.e. a type of heart failure caused by genetics or for which no cause is known. Now, researchers at the University Department of Internal Medicine II at the MedUni Vienna (Clinical Department of Cardiology), as part of an international cooperation, have successfully demonstrated the advantages of an implanted defibrillator (ICD) as a means of prevention in patients with moderately restricted cardiac function, and that patients with the condition must be treated as carefully as patients with ischaemic heart failure which has developed following a heart attack, for example.

16 Feb 2015

Study: Simple blood test could predict risk of developing dementia

Scientists at Rigshopitalet, Herlev Hospital and the University of Copenhagen identify a new biomarker that can predict the risk of developing dementia by way of a simple blood test. In the long term, this could mean better prevention and thus at least postponement of the illness and at best evading the development all together.

10 Feb 2015

Ohio State cardiologist answers questions relating to Hands-Only CPR

When a person's heart stops beating, every second counts. However, bystanders often fear giving cardiopulmonary resuscitation (CPR) to a victim.

9 Feb 2015

CPR depth and rate of compressions significantly impact survival, recovery of patients

The depth of chest compressions and the rate at which they were applied make a significant impact on survival and recovery of patients, a review of research by UT Southwestern Medical Center Emergency Medicine physicians shows.

6 Feb 2015

ISP shows promise in stopping fatal arrhythmias after heart attack

Case Western Reserve's chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.

3 Feb 2015

AP39 compound could help lower heart rate, blood pressure, and blood vessel stiffness

A gas that gives rotten eggs their distinctive odour could one day form the basis of new cardiovascular therapies.

29 Jan 2015

Kaleo, CHMI partner to reduce prescription drug-related deaths

Kaleo, a privately-held pharmaceutical company, today announced a national strategic partnership with the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, that will help support its goal of cutting prescription drug-related deaths in half, saving approximately 10,000 lives over five years.

27 Jan 2015

Understanding heart mutations that cause sudden cardiac arrest

New biosciences research at the University of Kent could point the way to greater understanding of the heart mutations that cause sudden cardiac arrest.

20 Jan 2015

Cardiac arrest associated with high mortality even in the world of Star Trek

The Star Trek universe is one of the most popular pieces of science fiction entertainment. Lots of the technologies seen in the TV and cinema episodes featuring Captain Kirk, Mr Spock or Captain Picard were once regarded as futuristic, but have now become reality - with examples including wireless communication or portable computers. In a recent study by the University Department of Emergency Medicine at the MedUni Vienna, the make-believe future of the human race depicted in this series has been used to investigate the frequency and mortality of cardiac arrests in the 24th century.

1 Jan 2015

LSDF announces $1.2 million in grants to foster advancement of promising health-related technologies

The Life Sciences Discovery Fund today announced $1.2 million in Proof of Concept grants to Washington-based organizations to foster the advancement of promising health-related technologies to commercial products. Also announced were two commercialization-focused awards, totaling $600,000, through a new funding program requiring external cash matching.

18 Dec 2014

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab).

16 Dec 2014

Reducing the risk of sudden cardiac arrest during sports

Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras. This important issue has long been a concern of heart specialists, for cardiac arrest often hits young, apparently healthy and athletic people out of the blue.

11 Dec 2014

New NHLBI grant to support development of prevention strategies for deadly heart condition

One of medicine's most prominent experts in sudden cardiac arrest has received a new $2.36 million grant to study how to better predict the deadly heart condition that kills an estimated 300,000 Americans each year.

3 Dec 2014

CHOP presents new findings on pediatric cardiovascular disease at AHA Scientific Sessions

Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2014 in Chicago.

20 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

UMHS opens Massey Emergency Critical Care Center

Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Study: Simple blood test could predict risk of developing dementia

Ohio State cardiologist answers questions relating to Hands-Only CPR

CPR depth and rate of compressions significantly impact survival, recovery of patients

ISP shows promise in stopping fatal arrhythmias after heart attack

AP39 compound could help lower heart rate, blood pressure, and blood vessel stiffness

Kaleo, CHMI partner to reduce prescription drug-related deaths

Understanding heart mutations that cause sudden cardiac arrest

Cardiac arrest associated with high mortality even in the world of Star Trek

LSDF announces $1.2 million in grants to foster advancement of promising health-related technologies

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Reducing the risk of sudden cardiac arrest during sports

New NHLBI grant to support development of prevention strategies for deadly heart condition

CHOP presents new findings on pediatric cardiovascular disease at AHA Scientific Sessions

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Hospital bed positioning can affect outcomes of stroke patients

Women delay seeking medical care for heart symptoms, put health at risk

ECMO improves survival, neurological outcomes in patients suffering from cardiac arrest

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in